Insider Trading History of Ryan Thomas F Jr

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Ryan Thomas F Jr since 2005. This trader's CIK number is 1263366. At the time of last reporting, Ryan Thomas F Jr was the Director of Repligen Corp. (stock ticker symbol RGEN). Also see all insider trading activities at Repligen Corp.



Yearly summary of insider trading at Repligen Corp (RGEN) by Ryan Thomas F Jr

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 RGEN 0 $0 2,000 $396,060 1,000 $38,760
2021 RGEN 0 $0 4,065 $1,076,460 2,285 $190,831
2020 RGEN 0 $0 12,050 $1,353,548 8,839 $419,073
2018 RGEN 0 $0 10,757 $493,016 4,696 $50,106
2017 RGEN 0 $0 4,000 $139,320 4,000 $12,880
2016 RGEN 0 $0 17,700 $466,879 5,000 $16,100
2015 RGEN 0 $0 30,000 $1,069,990 0 $0
2014 RGEN 0 $0 75,000 $1,605,120 75,000 $338,865
2013 RGEN 0 $0 109,000 $982,286 84,000 $350,805
2005 RGEN 20,000 $44,200 0 $0 0 $0


Insider trading of Repligen Corp (RGEN) by Ryan Thomas F Jr

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-01 RGEN Option Ex 1,000 38.76 38,760
2022-03-01 RGEN Sale 2,000 198.03 396,060
2021-11-02 RGEN Sale 1,285 302.00 388,070
2021-11-04 RGEN Sale 1,000 288.00 288,000
2021-11-02 RGEN Option Ex 1,285 128.18 164,711
2021-08-04 RGEN Sale 780 250.50 195,390
2021-03-03 RGEN Sale 1,000 205.00 205,000
2021-03-03 RGEN Option Ex 1,000 26.12 26,120
2020-11-11 RGEN Option Ex 934 38.76 36,201
2020-11-11 RGEN Sale 934 187.73 175,339
2020-07-31 RGEN Sale 3,095 151.87 470,022
2020-07-31 RGEN Option Ex 2,109 67.71 142,800
2020-03-16 RGEN Sale 1,000 91.48 91,480
2020-03-16 RGEN Option Ex 1,000 40.41 40,415
2020-03-04 RGEN Option Ex 4,796 41.63 199,657
2020-03-03 RGEN Sale 2,225 85.72 190,727
2020-03-04 RGEN Sale 4,796 88.82 425,980
2018-11-05 RGEN Sale 1,763 65.75 115,920
2018-08-22 RGEN Sale 2,366 51.44 121,697
2018-06-06 RGEN Sale 1,932 44.31 85,606
2018-03-08 RGEN Option Ex 4,696 10.67 50,106
2018-03-08 RGEN Sale 4,696 36.16 169,793
2017-03-20 RGEN Option Ex 4,000 3.22 12,880
2017-03-20 RGEN Sale 4,000 34.83 139,320
2016-09-14 RGEN Sale 2,700 32.59 87,979
2016-06-30 RGEN Sale 5,000 26.60 133,010
2016-06-28 RGEN Option Ex 5,000 3.22 16,100
2016-06-28 RGEN Sale 10,000 24.59 245,890
2015-05-08 RGEN Sale 20,000 37.19 743,800
2015-03-19 RGEN Sale 10,000 32.62 326,190
2014-11-13 RGEN Sale 10,000 23.81 238,100
2014-11-13 RGEN Option Ex 10,000 3.30 33,000
2014-06-27 RGEN Option Ex 10,000 4.13 41,300
2014-06-27 RGEN Sale 10,000 22.41 224,130
2014-06-24 RGEN Sale 10,000 21.78 217,780
2014-06-24 RGEN Option Ex 10,000 4.96 49,600
2014-06-05 RGEN Sale 45,000 20.56 925,110
2014-06-05 RGEN Option Ex 45,000 4.78 214,965
2013-05-16 RGEN Sale 4,000 8.95 35,800
2013-05-17 RGEN Sale 17,000 8.99 152,762
2013-05-15 RGEN Sale 1,961 9.00 17,641
2013-05-13 RGEN Option Ex 54,000 4.74 255,690
2013-05-15 RGEN Sale 14,884 8.96 133,420
2013-05-14 RGEN Sale 17,155 9.00 154,395
2013-05-15 RGEN Option Ex 14,884 3.10 46,140
2013-05-13 RGEN Sale 54,000 9.04 488,268
2013-05-14 RGEN Option Ex 15,116 3.24 48,975
2005-12-09 RGEN Buy 8,000 2.94 23,560
2005-03-10 RGEN Buy 12,000 1.72 20,640

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ryan Thomas F Jr (Director of Repligen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.